What is Bavdegalutamide used for?

Bavdegalutamide is being studied for its potential to treat prostate cancer and other types of neoplasms.

Is Bavdegalutamide approved for use?

No, Bavdegalutamide is currently in Phase 1 of clinical research and is not an approved medication.

What kind of drug is Bavdegalutamide?

It is classified as a small molecule compound.

Can Bavdegalutamide treat prostate cancer?

Research is currently looking into how Bavdegalutamide might work for prostate cancer.

What are the known side effects of Bavdegalutamide?

There is currently no data available regarding the side effects of Bavdegalutamide in the provided source.

How should I take Bavdegalutamide?

Because this drug is still in the research phase, there are no established instructions for patient use.

Bavdegalutamide | CAS 2222112-77-6 | CLCTZVRHDOAUGJ

Loading compound...

Small molecule research compound

Bavdegalutamide is a small molecule currently being studied in medical research. It is being investigated for its potential use in treating various types of neoplasms, including prostate cancer.

How it worksThe specific biological mechanism of how Bavdegalutamide works is not yet fully detailed in the provided research data.

Used for

Prostate cancerNeoplasms (tumors)

Conditions

Prostate cancerNeoplasms

Class

Small moleculeSmall molecule research compoundReproductive system

How to take

This compound is currently in the early stages of clinical development (Max Phase 1). Information regarding human dosing and administration is not yet available in the provided data bundle.

Talk to your doctor

Questions to ask

·Is Bavdegalutamide part of any clinical trials I can join?
·How does Bavdegalutamide differ from current prostate cancer treatments?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-25.

How to take

Talk to your doctor

Frequently asked questions (6)